References
- Al-Mondhiry H. A.B., Bilezikian S. B.&, Nossel H. L. Fibrinogen New York. An abnormal fibrinogen associated with thromboembolism: functional evaluation. Blood 1975; 45: 607
- Axén R., Porath J. &, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature (London) 1967; 214: 1302
- Babson A. L.&, Babson S. R. Comparative evaluation of a partial thromboplastin reagent containing a non-setting particulate activator. Am. J. clin. Path. 1974; 62: 856
- Beck E. A., Shainoff J. R., Vogel A. &, Jackson D. P. Functional evaluation of an inherited abnormal fibinogen: Fibrinogen Baltimore. J. clin. Invest. 1971; 50: 1874
- Blombäck B. &, Blombäck M. The molecular structure of fibrinogen. Ann. N. Y. Acad. Sci. 1972; 202: 77
- Boyer M. H., Shainoff J. R.&, Ratnoff O. D. Acceleration of fibrin polymerization by calcium ions. Blood 1972; 39: 382
- Collen D. Plasminogen and prothrombin metabolism in man. Acco (Academic Publishing Company), Leuven 1974
- Denson K. W.E. Techniques. Human Blood Coagulation, Haemostasis and Thrombosis, R. Biggs. Blackwell, Oxford 1976; 655
- Deutsch D. O.&, Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095
- Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 176
- Fuchs G., Egbring R., Havemann K. Fibrinogen Marburg, a new genetic variant of fibrinogen. Blut 1977; 34: 107
- Ganrot P. O. Crossed Immunoelectrophoresis. Scand. J. clin. Lab. Invest. 1972; 39(Suppl. 124. )
- Gralnick H. R., Givelber H. M., Finlayson J. S. A new congenital abnormality of human fibrinogen. Fibrinogen Bethesda II. Thrombos. Diathes. haemorrh. (Stuttg.) 1973; 29: 562
- Hansen M. S., Bang N. U., Barton R. D., Mattler L. E. Enhancement of blood coagulation by soluble fibrin complexes. J. expl Med. 1975; 141: 944
- Kazal L. A., Amsel S., Miller O. P., Tocantins L. M. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc. Soc. expl. Biol. (N. Y.) 1963; 113: 989
- Kudryk B. J., Collen D., Woods K. R., Blombäck B. Evidence for localization of polymerization sites in fibrinogen. J. biol. Chem. 1974; 249: 3322
- Laurell C.-B. Electroimmuno assay. Scand. J. clin. Lab. Invest. 1972; 21((Suppl.124))
- McFarlane A. S. Efficient trace-labelling of proteins with iodine. Nature 1958; 182: 53
- Morse E. E. The fibrinogenopathies. Ann. clin. Lab. Sci. 1978; 8: 234
- Mosesson M. W., Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry 1966; 5: 2829
- Müllertz S. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochem. J. 1974; 143: 273
- Müllertz S., Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem. J. 1976; 159: 545
- Owen C. A., Bowie E. J.W., Didisheim P., Thompson J. H. The Diagnosis of Bleeding Disorders. Little, Brown and Co, Boston. 1969
- Palascak J. E., Martinez J. Dysfibrinogenemia associated with liver disease. J. clin. Invest. 1977; 60: 89
- Ratnoff O. D., Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med. 1951; 37: 316
- Ratnoff O. D., Forman W. B. Criteria for the differentiation of dysfibrinogenemic states. Semin. Hematol. 1976; 13: 141
- Robbins K. C., Summaria L. Plasminogen and plasmin. Meth. Enzym. 1976; 45: 257
- Robertson B. R., Pandolfi M., Nilsson I. M. Response of local fibrinolytic activity to venous occlusion of arms and legs in healthy volunteers. Acta chiro. scand. 1972; 138: 437
- Samama M., Soria J., Soria C., Bousser J. Dysfibrinogénémie congenitale et familiale sans tendence hemorrhagique. Nouc. Rev. franç. Hemat. 1969; 9: 817
- Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Biochim. biophys. Acta 1975; 393: 55
- Thorsen S., Glas-Greenwalt P., Astrup T. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombos. Diathes. haemorrh. (Stuttg.) 1972; 28: 65
- Thorsen S., Müllertz S. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effect of 6-aminohexanoic acid and related compounds. Scand. J. clin. Lab. Invest. 1974; 34: 167
- Wallén P., Wiman B. Characterization of human plasminogen II. Separation and partial characterization of different molecular forms of human plasminogen. Biochim. biophys. Acta 1972; 257: 122
- Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Meth. Enzym. 1972; 26: 3
- Weiner A. M., Piatt T., Weber K. Amino-terminal sequence analysis of proteins purified on a nanomole scale by gel electrophoresis. J. biol. Chem. 1972; 247: 3242
- Winckelmann G. Kongenitale Dysfibrinogenämie. Bericht über eine neue Familie (Fibrinogen Wiesbaden). Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 1973; 55: 345